SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

SKIN ELEMENTS LIMITED(SKN)

Former (or subsequent) names

 

Shareholder links

Our website ranking of SKN: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services, Level 12 QV1 Building 250 St Georges Terrace Perth WA 6000

Tel : +61 8 9211 6670 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000SKN7
Address: Office 7, 36 Ord St, West Perth, Western Australia, 6005
Tel:  +61 8 9486 4792 Fax: +61 8 9486 4793

Date first listed: 06/01/2017
Company Secretary: Steven Wood, Kate Sainty
Sector: Household & Personal Products Industry Group: 
Activities: Developer of natural and organic skin care products

News & Events

Expand this box to read and print

OFX Transferring Money Internationally to Free

The suspension of trading in the securities of Skin Elements Limited will be lifted from the commencement of trading on Friday, 16 October 2020, following the release by SKN of an announcement in relation to a company update and a response to an ASX query

15/10/2020

The company issues a response to ASX Query Letter.

15/10/2020

SKN has continued to manufacture and sell its range of unique all natural skincare technologies. The company has recorded $70,916 in sales through its distributors and its online stores since 30 June 2020. SKN was not able to scale up additional production and use further production funding over the period because of the travel restrictions in place. Four key distributors' outlets are holding significant stocks of the Invisi-Shield Natural sanitiser following the initial impacts of the COVID-19 pandemic. SKN expects to gain sales orders through its distributor channel. Prudential Consultants has agreed to minimum sales commitments of $2.4 million over three years for the exclusive distribution of Invisi ShieldOrganics in New South Wales and Tasmania and also the distribution of Invisi Shield Organics outside of those territories on a non-exclusive basis. Prudential Consultants has taken delivery of samples and training materials and has commenced marketing activities for the Invisi-Shield Natural sanitiser product, however, is yet to place orders with SKN under the distribution agreement. The collaboration agreement with HCT is still on foot. SKN has taken delivery of 174 litres of Path-away and ordered a further 170 litres of Path-away in accordance with the agreement with HCT. Current value of orders and deliveries total $219,901.

15/10/2020

SKN is relying on the ASIC Relief and class waiver from ASX listing rule 4.5.1 to extend the lodgment date for its audited Annual Financial Report required to be lodged with ASIC under s319 of the Corporations Act to ASX. SKN is relying upon the ASIC Relief to provide the auditors additional time to obtain sufficient audit evidence given the increased difficulties caused by COVID-19 restrictions including the reduced ability to meet with distributors and production delays from the company's contract manufacturers in Melbourne and Queensland.

09/09/2020

The company lodges its Preliminary Final Report.

31/08/2020

SKN has made a placement to Mr Garth Alvares, of 2,000,000 ordinary fully paid shares at $0.06 per share with 200,000 free attaching listed options ($0.10 exp 31/12/20) raising $120,000 cash working capital. These shares are issued under the Company's LR 7.1 and LR7.1A capacity. Mr Alvares has recently been appointed as a director of, and become a shareholder of, Prudential Consultants Pty Ltd, a company appointed as a distributor to SKNs Invisi-Shield sanitiser as announced on 7 August 2020. SKN has issued 816,667 ordinary fully paid shares following conversion of $0.03 unlisted options, for $24,500 cash working capital.

27/08/2020

The company releases an Appendix 2A.

26/08/2020

The company releases a notice of Proposed issue of Securities - SKN.

26/08/2020

Skin Elements has entered into a binding distribution agreement with Sydney-based Prudential Consultants for the distribution of the Invisi Shield Organics hand sanitiser. The Agreement represents the first large-scale distribution contract for Invisi Shield Organics and covers major eastern Australian markets at a time of increased demand for hand sanitiser products. Prudential Consultants has agreed to minimum total sales commitments of $2.4 million over three years. Prudential Consultants is a preferred supplier of hand sanitiser to the NSW government and a registered supplier to the Tasmanian Department of Education.

07/08/2020

The company lodges its Appendix 4C - quarterly.

31/07/2020

The company issues a response to ASX Query Letter.

03/07/2020

The company releases a notice of Proposed issue of Securities - SKN.

26/06/2020

The Company has completed new securities issues: The issue of 707,702 ordinary fully paid shares following conversion of $0.03 unlisted options; The issue of 250,000 ordinary fully paid shares pursuant to the agreement with Absolut Solutions Pty Ltd for acquisition of the Invisi-Shield sanitiser intellectual property. These shares were issued under the Company's LR7.1 capacity and cleansed under the Company's cleansing prospectus dated 12 June 2020.

26/06/2020

The company releases an Appendix 2A.

26/06/2020

The company releases an Appendix 2A.

26/06/2020

SKN is in confidential and incomplete discussions with its corporate advisors in regard to a potential capital raising on terms consistent with those published. The Company has not executed any binding documentation in relation to the capital raising and there is no guarantee the capital raising will proceed under the terms as detailed in the article or at all.

18/06/2020

The company issues a prospectus that contains an offer of up to 1,000 Shares at an issue price of $0.08 to raise up to $80. The prospectus contains an offer of up to 1,000 listed options at an issue price of $0.01 to raise up to $10.

12/06/2020

The company releases an Appendix 2A.

12/06/2020

The company issues a notice of Proposed issue of Securities - SKN.

12/06/2020

The company has completed a number of new securities issues as follows: The issue of 3,451,845 ordinary fully paid shares following conversion of $0.03 unlisted options; The issue of 300,000 ordinary fully paid shares to Custodian Australia Pty Ltd for corporate financial services. These shares are issued under the Company's LR7.1 capacity.

12/06/2020

Independent laboratory testing of the SE Formula successfully demonstrates 99.99% effectiveness against Feline Coronavirus, a surrogate of Coronavirus COVID-19. Skin Elements is an established Australian skincare company with track record of USA FDA, TGA and other international regulatory approvals for its Soléo Organics sunscreen and PapayaActivs therapeutic skincare products.

29/05/2020

The company issues a response to ASX Query Letter.

22/05/2020

The securities of Skin Elements Limited will remain suspended from quotation pursuant to Listing Rule 17.3 pending ASX queries. SKN's securities will remain suspended until further notice.

19/05/2020

The securities of Skin Elements Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of SKN, pending the release of an announcement regarding laboratory test results.

12/05/2020

The suspension of trading in the securities of Skin Elements Limited will be lifted from the commencement of trading on Monday, 23 March 2020, following the release by SKN of an announcement regarding the launch of a new range of products.

20/03/2020

As part of its ongoing research and development into natural skincare formulas, Skin Elements has been collaborating with Absolut Solutions Pty Ltd over the past two years on research and development and test marketing in the hand sanitiser products sector. Skin Elements is now proceeding to bring the project to commercialisation as a range of personal care hand sanitisers under the Invisi Shield brand. Invisi Shield is a personal care sanitiser product range that offers personal users broad spectrum antimicrobial control and protection.

20/03/2020

The company issues a response to ASX Aware Query.

20/03/2020

The company issues a response to ASX Query Letter.

19/03/2020

The company releases an Appendix 2A.

17/03/2020

The non-renounceable entitlement offer closed the issue on 10 March 2020. The company has notified the underwriter of the entitlement shortfall and it is expected that the new securities will be issued and statements dispatched by 18 March 2020.

17/03/2020

The company issues a response to ASX Price Query.

16/03/2020

The securities of Skin Elements Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of SKN, pending the release of an announcement regarding the Company's response to an ASX query.

10/03/2020

The suspension of trading in the securities of Skin Elements Limited will be lifted from the commencement of trading on Monday, 2 December 2019, following the release by SKN of an announcement regarding the appointment of a director and receipt of a response to an ASX Query Letter.

02/12/2019

The company releases the Chairman's Address to Shareholders.

29/11/2019

The company releases the results of its meeting.

29/11/2019

The company issues a response to ASX Query Letter.

29/11/2019

The company releases its Corporate Governance Statement.

29/11/2019

The securities of Skin Elements Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of SKN, pending the release of a response to further queries from the ASX.

25/11/2019

The suspension of trading in the securities of Skin Elements Limited will be lifted from the commencement of trading on Tuesday, 26 March 2019, following the release by SKN of an announcement regarding a distribution agreement and response to an ASX price query.

25/03/2019

The company issues a response to ASX price query.

25/03/2019

The company issues a response to ASX queries regarding its accounts.

25/03/2019

The company has executed a proposed major distribution agreement with Henan Huatuo Health Management to deliver at least A$20 million of new sales of Skin Elements all natural skincare products over the years. HHHM intends to distribute Skin Elements products in China via its Huatuo Health Centres. HHHM will undertake a strategic investment in Skin Elements of $2.4 million. HHHM is further incentivised to grow the distribution and product expansion of Skin Elements sales into China over the next three years through the issue by SKN of performance shares.

25/03/2019

The securities of Skin Elements Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of SKN, pending the release of an announcement.

18/03/2019

The suspension of trading in the securities of Skin Elements Limited will be lifted immediately, following the release of a response to an ASX query.

02/05/2018

The issue of 500,000 fully paid ordinary shares in SKN to Indian Ocean Capital in lieu of cash consideration for the provision of corporate advisory services resulted in an unintentional breach of Listing Rule 10.11 as shareholder approval was not sought prior to the issue. ASX has permitted these shares to be sold on market and that that proceeds of any profit made on the sale be donated to charity. Indian Ocean has accepted this proposal and will seek to dispose of the shares as soon as possible.

02/05/2018

The company retracts, without any admission of liability, the announcement, the research report and the revenue forecasts released on 21 December 2017. SKN advises that the retracted information should be disregarded and that investors should not rely on the retracted information for their investment decisions.

02/05/2018

The company issues a response to ASX Query.

02/05/2018

The company lodges its Appendix 4C - quarterly.

01/05/2018

The company issues a response to ASX Query.

20/04/2018

The securities of Skin Elements Limited will be suspended from quotation immediately, in accordance with Listing Rule 17.3, pending a response to an ASX query.

17/04/2018

listed entity carried for record purposes only

06/01/2017

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

When will skn shares reopen,  its been 3 months of no trade!!

10/08/2020 21:15:02

Hi do you think the suspension would be lifted soon? What should I do with shares I am so tensed.

28/07/2020 18:16:52

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    07/12/2018Phil Giglia883,884$0.028$25,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Peter MaloneExecutive Chairman06/01/2017
    Phil GigliaIndependent Director23/11/2017
    Craig PiercyDirector29/11/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Zeling LiNon Exec Director03/05/201929/11/2019
    Jialin LiNon Exec Director03/05/201929/11/2019
    Luke MartinoIndependent Director06/01/201710/10/2019
    David HumannIndependent Director06/01/201723/11/2017

    Date of first appointment, title may have changed.